🇺🇸 Early aspirin Therapy in United States

Early aspirin Therapy (Early aspirin Therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Early aspirin Therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Early aspirin Therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Early aspirin Therapy in United States?

Second Affiliated Hospital, School of Medicine, Zhejiang University is the originator. The local marketing authorisation holder may differ — check the official source linked above.